This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Infinity Pharmaceuticals Inc (INFI)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 68.11M 175.74M 24.20M 20.42M
Receivables 0.00 0.00 218.19K 35.06K
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 224.94M 329.75M 117.98M 103.13M
Property, Plant & Equipment, Gross 27.30M 27.45M 27.29M 26.27M
Accumulated Depreciation & Depletion 23.29M 23.37M 22.71M 21.12M
Property, Plant & Equipment, Net 4.01M 4.08M 4.58M 5.15M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 1.76M 1.83M 1.93M 16.29M
Total Non-Current Assets 5.77M 5.91M 6.51M 21.44M
Liabilities & Shareholder Equity
Total Assets 230.71M 335.66M 124.49M 124.57M
Accounts Payable 6.38M 8.60M 5.95M 2.61M
Short Term Debt 6.67M 0.00 0.00 0.00
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 22.21M 18.66M 28.99M 27.75M
Long Term Debt 6.46M 0.00 37.55M 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 773.00K 6.79M 42.52M 47.33M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 7.23M 6.79M 80.07M 47.33M
Total Liabilities 29.44M 25.46M 109.06M 75.08M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 201.28M 310.20M 15.43M 49.48M
Common Par 48.00K 48.00K 26.72K 26.52K
Additional Paid In Capital 650.87M 633.04M 284.44M 278.41M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -449.80M -323.02M -269.05M -229.01M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 156.00K 134.00K 22.42K 53.98K
Total Capitalization 207.73M 310.20M 52.99M 49.48M
Total Equity 201.28M 310.20M 15.43M 49.48M
Total Liabilities & Stock Equity 230.71M 335.66M 124.49M 124.57M
Total Common Shares Outstanding 48.23M 47.50M 26.72M 26.52M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 47.94M 31.71M 26.62M 26.32M
Diluted Weighted Shares Outstanding 47.94M 31.71M 26.62M 26.32M
Number of Employees 180 154 190 168
Number of Part-Time Employees 0 0 0 0
INFI News

INFI Infinity Pharmaceuticals Inc

Analysts Ratings for INFI

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 5 5 5 5
Moderate Buy 1 1 1 1
Hold 3 3 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET INFI ANALYST REPORT

Brokerage Partners

INFI Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs